首页 | 本学科首页   官方微博 | 高级检索  
     

洛美利嗪抑制原代培养的脑微血管内皮细胞上P-糖蛋白的活性
引用本文:李运曼,康恺,方伟蓉. 洛美利嗪抑制原代培养的脑微血管内皮细胞上P-糖蛋白的活性[J]. 中国临床药理学与治疗学, 2006, 11(10): 1110-1114
作者姓名:李运曼  康恺  方伟蓉
作者单位:中国药科大学生理教研室,南京,210009,江苏
摘    要:目的:研究洛美利嗪对血脑屏障上P-糖蛋白功能活性的影响,寻找新型高效的P-糖蛋白抑制剂。方法:使用罗丹明123荧光指示剂研究脑微血管内皮细胞上P-糖蛋白的活性,应用RT-PCR技术分析洛美利嗪对mdr基因mRNA的影响。结果:洛美利嗪能够浓度依赖性地增加RBMECs中的罗丹明123水平,对RBMECs上mdr基因mRNA表达无影响。结论:洛美利嗪通过抑制P-糖蛋白功能活性而逆转血脑屏障上的多药耐药。

关 键 词:洛美利嗪  P-糖蛋白  血脑屏障
文章编号:1009-2501(2006)10-1110-05
收稿时间:2006-05-16
修稿时间:2006-06-29

Lomerizine inhibits activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers
LI Yun-man,KANG Kai,FANG Wei-rong. Lomerizine inhibits activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1110-1114
Authors:LI Yun-man  KANG Kai  FANG Wei-rong
Affiliation:Department of Physiology, China Pharmaceutical University, Nanjing 210009, Jiangsu, China
Abstract:AIM: To study the effect of Lomerizine on the activity of P-glycoprotein (P-gp) in the blood-brain barrier(BBB) and search for novel effective P-gp inhibiting agent against multidrug resistance. METHODS: Rhodamine123 (Rh123) was used to examine the activity of P-gp and RT-PCR to study the mdr mRNA expression in cultured rat brain microvessel endothelial cells (RBMECs). RESULTS: Lomerizine could increase the cellular Rh123 in RBMECs in a concentration-dependent manner. RT-PCR indicated that lomerizine could not down-regulate the expression of mdr mRNA. CONCLUSION: Lomerizine can reverse multidrug resistance in the blood-brain barrier by inhibiting the activity of P-gp.
Keywords:RT-PCR
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号